Streptococcus induces circulating CLA+ memory T-cell-dependent epidermal cell activation in psoriasis

Journal of Investigative Dermatology

Volumn 133, Issue 4, 2013, Pages 999-1007

  Ferran, Marta ^a   Galván, Ana B ^a   Rincón, Catalina ^b   Romeu, Ester R ^b   Sacrista, Marc ^a   Barboza, Erika ^b   Giménez Arnau, Ana ^a   Celada, Antonio ^b   Pujol, Ramon M ^a   Santamaria Babí, Luis F ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 8; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS CELL; EPIDERMIS HYPERPLASIA; GENE EXPRESSION; HELPER CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; STREPTOCOCCUS; SUPERNATANT; TH1 CELL; TH17 CELL; TH22 CELL; UPREGULATION;

EID: 84875217767     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.418     Document Type: Article

References (43)

1. Albanesi C, Scarponi C, Pallotta S et al. (2009) Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 206:249-58
2. Aragane Y, Riemann H, Bhardwaj RS et al. (1994) IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 153:5366-72
3. Baker BS, Garioch JJ, Hardman C et al. (1997) Induction of cutaneous lymphocyte-associated antigen expression by group A streptococcal antigens in psoriasis. Arch Dermatol Res 289:671-6
4. Baker BS, Powles A, Fry L (2006) Peptidoglycan: a major aetiological factor for psoriasis? Trends Immunol 27:545-51
5. Bender A, Heckl-Ostreicher B, Grondal EJ et al. (1993) Clonal specificity of human gamma delta T cells: V gamma 9 T-cell clones frequently recognize Plasmodium falciparum merozoites, Mycobacterium tuberculosis, and group-A streptococci. Int Arch Allergy Immunol 100:12-8
6. Bender A, Kabelitz D (1992) Preferential activation of peripheral blood V gamma 9 gamma/delta T cells by group A, B and C but not group D or F streptococci. Clin Exp Immunol 89:301-4
7. Besgen P, Trommler P, Vollmer S et al. (2010) Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: potential targets of a streptococcal-induced autoimmune response in psoriasis. J Immunol 184:5392-402
8. Brown DW, Baker BS, Ovigne JM et al. (2000) Skin CD4 T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis. J Invest Dermatol 114:576-80
9. Cai Y, Shen X, Ding C et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35:596-610
10. Cai YH, Lu ZY, Shi RF et al. (2009) Enhanced proliferation and activation of peripheral blood mononuclear cells in patients with psoriasis vulgaris mediated by streptococcal antigen with bacterial DNA. J Invest Dermatol 129:2653-60
11. Caruso R, Botti E, Sarra M et al. (2009) Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 15:1013-5
12. Chan JR, Blumenschein W, Murphy E et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203:2577-87
13. Davison SC, Ballsdon A, Allen MH et al. (2001) Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques. Exp Dermatol 10:280-5
14. Diluvio L, Vollmer S, Besgen P et al. (2006) Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol 176:7104-11
15. Eyerich S, Eyerich K, Pennino D et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin Invest 119:3573-85
16. Ferran M, Gimenez-Arnau AM, Bellosillo B et al. (2008) Circulating CLA T cell subsets inversely correlate with disease severity and extension in acute psoriasis but not in chronic plaque psoriasis. Eur J Dermatol 18:647-50
17. Fry L, Powles AV, Corcoran S et al. (2006) HLA Cw 06 is not essential for streptococcal-induced psoriasis. Br J Dermatol 154:850-3
18. Gottlieb AB, Luster AD, Posnett DN et al. (1988) Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 168: 941-8
19. Grinlinton FM, Skinner MA, Birchall NM et al. (1993) Gamma delta T cells from patients with psoriatic and rheumatoid arthritis respond to streptococcal antigen. J Rheumatol 20:982-7
20. Gudjonsson JE, Karason A, Runarsdottir EH et al. (2006) Distinct clinical differences between HLA-Cw 0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126:740-5
21. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B et al. (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149:530-4
22. Guttman-Yassky E, Nograles KE, Krueger JG (2011) Contrasting pathogenesis of atopic dermatitis and psoriasis-Part II: Immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 127:1420-32
23. Johnston A, Gudjonsson JE, Sigmundsdottir H et al. (2004) Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8() T cells. Clin Exp Immunol 138:83-93
24. Laggner U, Di MP, Perera GK et al. (2011) Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 187:2783-93
25. Lee E, Trepicchio WL, Oestreicher JL et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-30
26. Leung DY, Travers JB, Giorno R et al. (1995) Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96:2106-12
27. Mallbris L, Larsson P, Bergqvist S et al. (2005) Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 124:499-504
28. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361: 496-9
29. Nograles KE, Zaba LC, Guttman-Yassky E et al. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte- response pathways. Br J Dermatol 159:1092-102
30. Norrlind R (1955) The significance of infections in the origination of psoriasis. Acta Rheumatol Scand 1:135-44
31. Pont-Giralt M, Gimenez-Arnau AM, Pujol RM et al. (2006) Circulating CLA() T cells from acute and chronic psoriasis patients manifest a different activation state and correlation with disease severity and extension. J Invest Dermatol 126:227-8
32. Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341:1817-28
33. Santamaria-Babi LF (2004) CLA() T cells in cutaneous diseases. Eur J Dermatol 14:13-8
34. Santamaria Babi LF, Picker LJ, Perez Soler MT et al. (1995a) Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181:1935-40
35. Santamaria Babi LF, Moser R, Perez Soler MT et al. (1995b) Migration of skinhoming T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte functionassociated antigen-1 (LFA-1). J Immunol 154:1543-50
36. Shi X, Jin L, Dang E et al. (2011) IL-17A upregulates keratin 17 expression in keratinocytes through S. J Invest Dermatol 131:2401-8
37. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al. (2001) The frequency of CLA CD8 T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126:365-9
38. Sigmundsdottir H, Gudjonsson JE, Valdimarsson H (2003) Interleukin-12 alone can not enhance the expression of the cutaneous lymphocyte associated antigen (CLA) by superantigen-stimulated T lymphocytes. Clin Exp Immunol 132:430-5
39. Sticherling M, Bornscheuer E, Schroder JM et al. (1991) Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 96:26-30
40. Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B et al. (2012) Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J Immunol 188:5160-5
41. Tonel G, Conrad C, Laggner U et al. (2010) Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol 185:5688-91
42. Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL et al. (2009) Psoriasis as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494-501
43. Vissers WH, Arndtz CH, Muys L et al. (2004) Memory effector (CD45RO) and cytotoxic (CD8) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 150:852-9